Researchers at the University of Zurich have developed a new artificial intelligence-enhanced version of the GRACE (Global Registry of Acute Coronary Events) scoring system that provides a personalized and accurate method for assessing coronary risk of patients with non-ST-elevation acute coronary syndrome (NSTE-ACS). Published in The Lancet Digital Health, the new findings revealed by the development of GRACE 3.0 suggest that current approaches to treatment stratification for NSTE-ACS may be misclassifying patients and could be improved by leveraging individualized treatment effect predictions.

“GRACE 3.0 is the most advanced and practical tool yet for treating patients with the most common type of heart attacks ,” said senior author Thomas F. Lüscher, PhD, director of the Center f

See Full Page